Default company panoramic image
Eef45873 e2fe 425c a597 c6cadc88ff59

Hooke Bio

Hooke Bio have developed a microfluidic, high throughput, cell based, platform designed to increase drug screening rate and reduce costs for the pharma industry

  • Stage Prototype Ready
  • Industry Biotechnology
  • Location Limerick, Ireland
  • Currency EUR
  • Founded March 2014
  • Employees 4
  • Incorporation Type LLC
  • Website hookebio.com

Company Summary

Hooke Bio have developed a unique, ultrahigh-throughput, microfluidic platform for running biochemical and cellular assays up to 16 times faster and at one quarter of the cost of current technologies. This technology is protected by a number of patent applications. Hooke has a highly experienced and skilled core team and has already attracted significant funding (€1.3m subject to DD) from private and exchequer sources.

Team

  • Dr. Mark Lyons (D.Phil. Oxford) has worked as Team Leader at Radisens Diagnostics and Olympus Diagnostics and has lead multidisciplinary teams in successful delivery of key milestones to multinational companies as well as successive multi-million euro European Space Agency projects.

  • Dr. Finola Cliffe (PhD Limerick) is a Research Fellow at the Stokes Institute. Finola has been a team member of Hooke Bio since 2014, working as a senior scientist with the interdisciplinary team of scientists and engineers. She has previously held a number of industrial research positions.

  • 5ab4bbe5 2ac0 4d19 baba 519aabb7d87e
    Senior Biochemist

  • 579fe705 6a93 4c54 949a d91536b6da7e
    Executive PA